Last updated: 29 August 2024 at 4:30pm EST

Christopher Fenimore Net Worth




The estimated Net Worth of Christopher R. Fenimore is at least $20.9 Million dollars as of 28 August 2024. Mr. Fenimore owns over 5,680 units of Regeneron Pharmaceuticals stock worth over $28,536 and over the last 7 years he sold REGN stock worth over $20,833,774. In addition, he makes $0 as Vice President and Controller at Regeneron Pharmaceuticals.

Mr. Fenimore REGN stock SEC Form 4 insiders trading

Christopher has made over 25 trades of the Regeneron Pharmaceuticals stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 5,680 units of REGN stock worth $6,846,274 on 28 August 2024.

The largest trade he's ever made was exercising 13,500 units of Regeneron Pharmaceuticals stock on 20 August 2021 worth over $2,418,255. On average, Christopher trades about 3,499 units every 71 days since 2017. As of 28 August 2024 he still owns at least 25 units of Regeneron Pharmaceuticals stock.

You can see the complete history of Mr. Fenimore stock trades at the bottom of the page.





Christopher Fenimore biography

Christopher R. Fenimore serves as Vice President, Controller of the Company since March 2017. From January 2017 to March 2017, he served as Vice President, Deputy Controller, and previously served as Vice President, Financial Planning from January 2012 to December 2016. Prior to joining the Company in 2003, he was Vice President, Finance at Mojave Therapeutics, Inc. Mr. Fenimore’s prior experience includes working as a supervising senior accountant at KPMG, as well as healthcare industry- focused venture capital and investment banking roles. Mr. Fenimore holds an M.A. in Biotechnology from Columbia University, an M.B.A. in Professional Accounting from Rutgers Business School, and a B.A. in Economics from Rutgers University. Mr. Fenimore is a Certified Public Accountant in the State of New York.



How old is Christopher Fenimore?

Christopher Fenimore is 49, he's been the Vice President and Controller of Regeneron Pharmaceuticals since 2017. There are 22 older and 2 younger executives at Regeneron Pharmaceuticals. The oldest executive at Regeneron Pharmaceuticals, Inc. is P. Roy Vagelos, 90, who is the Chairman of the Board, Director.

Insiders trading at Regeneron Pharmaceuticals

Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis, and Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.



What does Regeneron Pharmaceuticals do?

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.



What does Regeneron Pharmaceuticals's logo look like?

Regeneron Pharmaceuticals, Inc. logo

Complete history of Mr. Fenimore stock trades at Regeneron Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
28 Aug 2024 Christopher R. Fenimore
SVP Finance and CFO
Sale 5,680 $1,205.33 $6,846,274
28 Aug 2024
25
9 Feb 2024 Christopher R. Fenimore
SVP Finance and CFO
Sale 4,919 $953.31 $4,689,332
9 Feb 2024
14,372
23 Jan 2024 Christopher R. Fenimore
SVP Finance and CFO
Option 10,000 $477.67 $4,776,700
23 Jan 2024
22,874
3 Jan 2024 Christopher R. Fenimore
SVP Finance and CFO
Option 10,000 $477.67 $4,776,700
3 Jan 2024
20,329
27 Dec 2023 Christopher R. Fenimore
SVP Finance and CFO
Sale 2,448 $856.71 $2,097,226
27 Dec 2023
14,372
21 Dec 2023 Christopher R. Fenimore
SVP Finance and CFO
Sale 1,930 $844.30 $1,629,499
21 Dec 2023
16,820
23 Aug 2023 Christopher R. Fenimore
SVP Finance and CFO
Option 7,000 $399.66 $2,797,620
23 Aug 2023
26,140
23 Mar 2023 Christopher R. Fenimore
SVP Finance and CFO
Sale 2,192 $806.47 $1,767,782
23 Mar 2023
18,409
3 Feb 2023 Christopher R. Fenimore
SVP Finance and CFO
Option 5,000 $270.43 $1,352,150
3 Feb 2023
23,581
5 Oct 2022 Christopher R. Fenimore
SVP Finance and CFO
Sale 1,844 $749.00 $1,381,156
5 Oct 2022
16,425
3 Oct 2022 Christopher R. Fenimore
SVP Finance and CFO
Sale 3,346 $724.00 $2,422,504
3 Oct 2022
18,269
8 Apr 2022 Christopher R. Fenimore
SVP Finance and CFO
Option 7,450 $364.23 $2,713,514
8 Apr 2022
30,066
31 Mar 2022 Christopher R. Fenimore
SVP Finance and CFO
Option 12,000 $317.97 $3,815,640
31 Mar 2022
31,628
20 Aug 2021 Christopher R. Fenimore
SVP Finance and CFO
Option 13,500 $179.13 $2,418,255
20 Aug 2021
32,520
20 Jul 2020 Christopher R. Fenimore
SVP Finance and CFO
Option 12,224 $156.01 $1,907,066
20 Jul 2020
21,210
15 Jun 2020 Christopher R. Fenimore
SVP Finance and CFO
Option 9,406 $47.07 $442,740
15 Jun 2020
18,833
1 Apr 2020 Christopher R. Fenimore
SVP Finance and CFO
Option 1,200 $30.63 $36,756
1 Apr 2020
14,297
24 Jan 2020 Christopher R. Fenimore
SVP Finance and CFO
Option 500 $30.63 $15,315
24 Jan 2020
13,097
20 Dec 2019 Christopher R. Fenimore
SVP Finance and CFO
Option 400 $30.63 $12,252
20 Dec 2019
12,597
11 Dec 2019 Christopher R. Fenimore
SVP Finance and CFO
Option 3,100 $52.03 $161,293
11 Dec 2019
15,297
18 Apr 2019 Christopher R. Fenimore
SVP Finance and CFO
Option 350 $21.25 $7,438
18 Apr 2019
7,446
18 Jan 2019 Christopher R. Fenimore
SVP Finance and CFO
Option 150 $21.25 $3,188
18 Jan 2019
7,246
19 Dec 2018 Christopher R. Fenimore
SVP Finance and CFO
Option 4,125 $46.99 $193,834
19 Dec 2018
8,944
30 Aug 2018 Christopher R. Fenimore
SVP Finance and CFO
Option 50 $21.25 $1,063
30 Aug 2018
200
16 Jan 2018 Christopher R. Fenimore
SVP Finance and CFO
Option 150 $21.25 $3,188
16 Jan 2018
150


Regeneron Pharmaceuticals executives and stock owners

Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: